Skip to main content

Table 2 Rates of events in individual studies

From: Benefits and harms of citrate locking solutions for hemodialysis catheters: a systematic review and meta-analysis

Study Citrate Heparin
Events Catheter days Events/1000 catheter days Events Catheter days Events/1000 catheter days
Mortality
Power 5 19008 0.26 5 17100 0.29
Weijmer 13 8181 1.59 18 8049 2.24
MacRae 4 2272 1.76 5 1818 2.75
Bacteremia
Power 13 19008 0.68 12 17100 0.70
Weijmer 9 8181 1.10 33 8049 4.10
MacRae 5 2272 2.20 6 1818 3.30
Access-related hospitalization
Power 17 19008 0.89 12 17100 0.70
Weijmer 6 8181 0.70 21 8049 2.70
Catheter replacement
Buturovic 1 2272 1.96 1 1818 4.35
MacRae 8 2272 3.52 5 1818 2.75
Weijmer 27 8181 3.21 29 8049 3.56
Thrombolysis
MacRae 13 2272 5.72 13 1818 7.15
Power 1 19008 0.06 1 17100 0.04
Weijmer 69 8181 8.28 63 8049 7.88
Bleeding
MacRae 25 2272 11.00 37 1818 20.35
Weijmer 5 8181 0.60 16 8049 2.00